Skip to main content
SpringerLink
Log in

Litigation may help define drug risks

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Kesselheim AS, Avorn J.The role of litigation in defining drug risks. JAMA: the Journal of the American Medical Association 297: 308-311, No. 3, 17 Jan 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Litigation may help define drug risks. React. Wkly. 1136, 3 (2007). https://doi.org/10.2165/00128415-200711360-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711360-00008

Keywords

Search

Navigation